The active substance, artemisinin, is a plant substance found in the leaves and flowers of the annual mugwort (Artemisia annua). Artemisinin is used worldwide to treat malaria.
Artemisinin has been shown in recent decades to be effective in a variety of cancers, particularly those of the lower abdomen (ovaries, uterus, and prostate).
Certain cellular organelles, the lysosomes and the lysosomal iron they contain, play a central role in this regard. Lysosomes are normally responsible for the degradation of cellular components that are no longer needed by the cell.
Together with artemisinin, iron reacts in the lysosomes. This produces, among other things, oxygen free radicals. The radicals are extremely reactive and oxidize certain components of the lysosomes. These changes trigger a signaling cascade that initiates programmed cell death in the mitochondria.
Artemisinin can block the process of autophagy, which is the breakdown of cellular components, and which helps cancer cells survive by allowing them to take unneeded cellular components into the lysosomes and recycle them there. Artemisinin may also prevent cancer cells from multiplying further.
In addition to its high efficacy, artemisinin has many advantages: it is selective, it is toxic to cancer cells, and it has almost no effect on normal cells. Cancer cells that are resistant to chemotherapy also respond or are killed.
Artemisinin is used as a complement to biological cancer therapy. The treatment is integrated into a therapeutic concept adapted to each patient.
Artemisinin is also a powerful anti-viral and anti-inflammatory; it is proven in the treatment of COVID, Lyme disease, and arthritic pain.
|Vitamins C||Immunity - Cancers - Energy - Cardiovascular disorders - Viral infections|
Detoxification (general, drug, vaccine, anesthesia, ...)
Synergy with ozone therapy
Chronic fatigue / fibromyalgia
Cardiovascular diseases (hypertension, heart failure, pericarditis, stroke, type 2 diabetes...) and drug cardiotoxicity
Microbial infections: Lyme, Covid 19, flu, ...